UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________

FORM 8-K

CURRENT ~~REPORT~~REPORTPURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934

~~Pursuant~~Date ~~to Section 13 or 15(d)~~ of ~~The Securities Exchange Act of 1934~~Report:

~~Date of Report~~ (Date of earliest event reported)~~: September 30, 2016~~

~~Medical~~March ~~Imaging~~23, ~~Corp.~~2018

____________________________

MEDICAL IMAGING CORP.

(Exact name of registrant as specified in charter)

Nevada	333-1364363	98-0493698
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

NEVADA

848 N. Rainbow Blvd. #2494 Las Vegas, Nevada		89107
(Address of principal executive offices)		(Zip Code)

(State or other Jurisdiction of Incorporation or Organization)

Registrant’s telephone number, including area code (877) 331-3444

333-1364363

848 N. Rainbow Blvd. #2494

Las Vegas, Nevada 89107

98-0493698

(Commission File Number)

(Address of Principal Executive Offices and zip code)

(IRS Employer Identification No.)

(~~Former name or former address, if changed since last report.~~877) 331-3444

~~Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions~~ (~~see~~Registrant’s ~~General~~telephone ~~Instructions~~number, ~~A.2.~~including ~~below~~area code):

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~Indicate 5by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.07405 —of ~~Submission~~this chapter) or Rule 12b-2 of ~~Matters~~the toSecurities aExchange ~~Vote~~Act of ~~Security~~1934 ~~Holders~~(§240.12b-2 of this chapter).

~~The~~Emerging ~~2016~~growth ~~Annual~~company ~~Meeting of Stockholders (the “Annual Meeting”) of Medical Imaging Corp. (the “Company”) was held on September 30, 2016.~~o

~~The~~If ~~Company’s~~an ~~stockholders~~emerging ~~voted~~growth oncompany, ~~three~~indicate ~~proposals~~by ascheck ~~follows:~~mark toif ~~elect Company directors for~~ the ~~ensuing~~registrant ~~year~~has ~~(Proposal~~elected ~~1);~~not Toto ~~approve,~~use ~~by non-binding vote,~~ the ~~Company’s~~extended ~~executive~~transition ~~compensation~~period ~~(Proposal~~for 2)complying ~~and~~with toany ~~ratify~~new ~~the~~or ~~selection~~revised byfinancial ~~the~~accounting ~~Company’s~~standards ~~Board~~provided ofpursuant ~~Directors~~to Section 13(a) of ~~Accell as~~ the ~~Company’s~~Exchange ~~independent registered public accounting firm for the fiscal year ending December 31, 2016 (Proposal 3)~~Act. o

~~All~~Item ~~nominees~~5.02 ~~for~~— ~~election~~Departure toof ~~the Board as~~ Directors ~~were~~or ~~elected~~Certain toOfficers; ~~serve~~Election ~~until the 2017 Annual Meeting~~ of ~~Stockholders~~Directors; ~~and~~Appointment until their respective successors are elected and qualified, or until such director’s earlier death, resignation or removal. The Stockholders approved the non-binding vote for Proposal 2. The stockholders ratified Proposal 3. The number of ~~votes~~Certain ~~cast~~Officers; ~~for,~~Compensatory ~~against~~Arrangements ~~or withheld and the number~~ of ~~abstentions~~Certain ~~and broker non-votes with respect to each Proposal is set forth below.~~Officers

Proposal 1	Shares For	Shares Withheld	Broker Non-Votes
Mitchel Geisler	15,612,447	12,000	0
Richard Jagodnik	15,612,447	12,000	0

Effective March 23, 2018 Mr. Richard Jagodnik resigned his positions with the company including Chief Financial Officer and Director for Medical Imaging Corp., and Director for Custom Teleradiology Services (“CTS”).

		Shares For		Shares Against		Shares Abstaining		Broker Non-Votes
Proposal 2		15,121,447		97,000		1,000		0

SIGNATURES

		Shares For		Shares Against		Shares Abstaining		Broker Non-Votes
Proposal 3		16,247,621		137,153		0		0

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

SIGNATURES


	Medical Imaging Corp.
	(Registrant)


Dated: April 13, 2018	By:	/s/ Mitchell Geisler
		Name: Mitchell Geisler
		Title: Chief Executive Officer

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~2

	Medical Imaging Corp.
Dated: October 5, 2016	By:	/s/ Mitchell Geisler
		Name: Mitchell Geisler
		Title: Chief Executive Officer

Filing Compare · MEDICAL IMAGING CORP.